NEXTCURE, INC Accumulated Other Comprehensive Income
NEXTCURE, INC (NXTC) had Accumulated Other Comprehensive Income of -$3.00 thousand as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-18
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $21.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $17.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$3.00K S-4 · filed 2026-08-18 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $21.00K S-4 · filed 2026-08-18 |
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$7.00K 10-Q · filed 2025-08-07 |
| 2024-12-31 | $4.00K S-4 · filed 2026-08-18 |
| 2024-09-30 | $76.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$86.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$182.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$222.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$603.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$925.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$803.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$1.49M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$2.40M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$2.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$2.20M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$663.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | -$129.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$195.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $179.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $779.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.94M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$543.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$38.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | -$58.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |